Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TEPSIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CLN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUSC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLUAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BECN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTHLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXA13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA1549L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADD3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100506639 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FER1L4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G3BP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFAP221 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on